These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 22678360)

  • 1. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.
    Osterloh JM; Yang J; Rooney TM; Fox AN; Adalbert R; Powell EH; Sheehan AE; Avery MA; Hackett R; Logan MA; MacDonald JM; Ziegenfuss JS; Milde S; Hou YJ; Nathan C; Ding A; Brown RH; Conforti L; Coleman M; Tessier-Lavigne M; Züchner S; Freeman MR
    Science; 2012 Jul; 337(6093):481-4. PubMed ID: 22678360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroscience. dSarm-ing axon degeneration.
    Yu XM; Luo L
    Science; 2012 Jul; 337(6093):418-9. PubMed ID: 22837513
    [No Abstract]   [Full Text] [Related]  

  • 3. Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly.
    Neukomm LJ; Burdett TC; Seeds AM; Hampel S; Coutinho-Budd JC; Farley JE; Wong J; Karadeniz YB; Osterloh JM; Sheehan AE; Freeman MR
    Neuron; 2017 Jul; 95(1):78-91.e5. PubMed ID: 28683272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injury-Induced Inhibition of Bystander Neurons Requires dSarm and Signaling from Glia.
    Hsu JM; Kang Y; Corty MM; Mathieson D; Peters OM; Freeman MR
    Neuron; 2021 Feb; 109(3):473-487.e5. PubMed ID: 33296670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor Pebbled/RREB1 regulates injury-induced axon degeneration.
    Farley JE; Burdett TC; Barria R; Neukomm LJ; Kenna KP; Landers JE; Freeman MR
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1358-1363. PubMed ID: 29295933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
    Summers DW; Gibson DA; DiAntonio A; Milbrandt J
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
    Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
    Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury.
    Fernandes KA; Mitchell KL; Patel A; Marola OJ; Shrager P; Zack DJ; Libby RT; Welsbie DS
    Exp Eye Res; 2018 Jun; 171():54-61. PubMed ID: 29526794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
    White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
    Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
    Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
    Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
    Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
    Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
    Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NAD
    Llobet Rosell A; Paglione M; Gilley J; Kocia M; Perillo G; Gasparrini M; Cialabrini L; Raffaelli N; Angeletti C; Orsomando G; Wu PH; Coleman MP; Loreto A; Neukomm LJ
    Elife; 2022 Dec; 11():. PubMed ID: 36476387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Peters OM; Lewis EA; Osterloh JM; Weiss A; Salameh JS; Metterville J; Brown RH; Freeman MR
    Hum Mol Genet; 2018 Nov; 27(21):3761-3771. PubMed ID: 30010873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of degenerative spheroids after injury.
    Yong Y; Gamage K; Cushman C; Spano A; Deppmann C
    Sci Rep; 2020 Sep; 10(1):15472. PubMed ID: 32963272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SARM1 axon degeneration pathway: control of the NAD
    Figley MD; DiAntonio A
    Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.
    Henninger N; Bouley J; Sikoglu EM; An J; Moore CM; King JA; Bowser R; Freeman MR; Brown RH
    Brain; 2016 Apr; 139(Pt 4):1094-105. PubMed ID: 26912636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecule SARM1 Inhibitors Recapitulate the SARM1
    Hughes RO; Bosanac T; Mao X; Engber TM; DiAntonio A; Milbrandt J; Devraj R; Krauss R
    Cell Rep; 2021 Jan; 34(1):108588. PubMed ID: 33406435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.